Effects of long non coding RNA tumor protein translation controlled antisense RNA 1 on proliferation and invasion of colon cancer cells
杨华湘,汪道函,付蔚华,孙伟林,赵宗贤,李树亮,李世龙,陆礼
DOI: https://doi.org/10.3760/cma.j.cn421213-20201019-00767
2021-01-01
Abstract:Objective:To investigate the expression and clinical significance of long non-coding RNA (lncRNA) tumor protein translation controlled antisense RNA 1 (TPT1-AS1) in colon cancer and explore its effects on proliferation, cell cycle, migration and invasion of colon cancer cells.Methods:Cancer tissue specimens and normal adjacent tissue specimens of 72 patients with colon cancer who underwent radical surgery for colon cancer in the Department of Gastrointestinal Surgery of Tianjin Medical University General Hospital from July 2016 to September 2017 were collected. Real-time quantitative polymerase chain reaction (RT-qPCR) was used to detect the relative expression of lncRNA TPT1-AS1 in colon cancer tissues, and the correlation between lncRNA TPT1-AS1 expression and clinicopathological characteristics of colon cancer was analyzed. lncRNA TPT1-AS1 knockdown vector and control vector (si-TP1-AS1 and si-NC) were constructed and set as knockdown group and control group respectively. Proliferation, cell cycle arrest, migration and invasion ability of colon cancer cells (SW620) were detected by cell counting kit-8 (CCK-8) cell proliferation assay, cell cycle analysis and Transwell assay, respectively. T-test was used for comparison between metrology data groups, and χ2 test was used for enumulation data. Results:The relative expression of lncRNA TP1-AS1 in colon cancer tissues was significantly higher than that in corresponding adjacent tissues (3.99±0.21 vs. 1.78±0.09, t=35.433, P<0.05), and its expression was positively correlated with TNM staging ( χ2==9.000, P<0.05) and distant metastasis ( χ2=4.600, P<0.05). The results of CCK-8 assay showed that the proliferation ability of SW620 cells was significantly reduced after TPT1-AS1 knockdown for 48 h (0.47±0.02 vs. 0.83±0.05, t=10.543, P<0.05) and 72 h (0.69±0.02 vs. 1.23±0.09, t=10.145, P<0.05). Flow cytometry showed that after TPT1-AS1 knockdown, the proportion of cells in G 0/G 1 phase was significantly increased [(68.47±2.79)% vs. (44.69±1.26)%, t=14.672, P<0.05], and that in S phase [(22.87±1.96)% vs. (37.48±1.57)%, t=17.246, P<0.05] and G 2/M phase [(8.22±0.87)% vs. (20.78±0.45)%, t=18.772, P<0.05] was dramatically decreased. Transwell assay showed that the migration and invasion ability of SW620 cells was significantly reduced after TPT1-AS1 was knocked down as compared with the control group (47±5 vs. 122±8, t=19.578, P<0.05). Conclusion:This study confirmed that lncRNA TPT1-AS1 was up-regulated in colon cancer. Knockdown of TPT1-AS1 can inhibit the proliferation, G1/S phase transition, migration and invasion of colon cancer cells.